By Jonathan Stempel NEW YORK, April 17 (Reuters) - A U.S. judge has rejected Bayer's request for an injunction to block ...

Add Yahoo as a preferred source to see more of our stories on Google. Thousands of men suffering from prostate cancer are set to gain access to a life-extending drug on the NHS following a significant ...

Early-stage trials of a new drug for advanced prostate cancer have yielded "remarkable" results, according to medical experts. This innovative treatment, an immunotherapy designed to harness the ...

That fourth drug is Pomalyst, a treatment from Bristol Myers Squibb for multiple myeloma. That’s a relatively uncommon cancer ...

Add Yahoo as a preferred source to see more of our stories on Google. A drug for advanced prostate cancer has shown “remarkable” results in an early-stage trial, experts have said. The treatment, a ...

Taking one-fourth the standard dose of a widely used drug for prostate cancer with a low-fat breakfast can be as effective - and four times less expensive - as taking the standard dose as recommended: ...

Prefer Newsweek on Google to see more of our trusted coverage when you search. Those with prostate cancer that returns after surgery or radiation—and typically face a high risk of the disease ...

A new study has found that metformin, a widely prescribed diabetes drug, may mimic one of exercise's core biological effects ...

Drugs used for prostate cancer may not increase bleeding or clotting risks when used with blood thinners, thus providing ...

Thousands of men suffering from prostate cancer are set to gain access to a life-extending drug on the NHS following a significant expansion of eligibility criteria. Previously, the hormone therapy ...

Diabetes drug metformin may mimic exercise effects in prostate cancer, supporting weight, metabolism and overall health ...